Exagen (XGN) Competitors

Exagen (NASDAQ:XGN) and The Pennant Group (NASDAQ:PNTG) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, media sentiment, profitability, dividends, analyst recommendations and valuation.

Which has more volatility and risk, XGN or PNTG?

Exagen has a beta of 1.61, meaning that its stock price is 61% more volatile than the S&P 500. Comparatively, The Pennant Group has a beta of 1.48, meaning that its stock price is 48% more volatile than the S&P 500.

Is XGN or PNTG more profitable?

The Pennant Group has a net margin of 3.36% compared to Exagen's net margin of -28.85%. The Pennant Group's return on equity of 9.85% beat Exagen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Exagen	-28.85%	-130.38%	-34.69%
The Pennant Group	3.36%	9.85%	4.04%

Do insiders and institutionals have more ownership in XGN or PNTG?

75.3% of Exagen shares are owned by institutional investors. Comparatively, 85.9% of The Pennant Group shares are owned by institutional investors. 12.6% of Exagen shares are owned by insiders. Comparatively, 5.4% of The Pennant Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Does the media refer more to XGN or PNTG?

In the previous week, The Pennant Group had 2 more articles in the media than Exagen. MarketBeat recorded 4 mentions for The Pennant Group and 2 mentions for Exagen. Exagen's average media sentiment score of 1.77 beat The Pennant Group's score of 1.76 indicating that Exagen is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Exagen	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
The Pennant Group	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Which has preferable earnings and valuation, XGN or PNTG?

The Pennant Group has higher revenue and earnings than Exagen. Exagen is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Exagen	$55.64M	3.85	-$15.11M	-$0.89	-10.94
The Pennant Group	$798.92M	1.05	$22.56M	$0.78	31.14

Do analysts rate XGN or PNTG?

Exagen currently has a consensus target price of $11.25, suggesting a potential upside of 15.50%. The Pennant Group has a consensus target price of $33.40, suggesting a potential upside of 37.51%. Given The Pennant Group's higher probable upside, analysts clearly believe The Pennant Group is more favorable than Exagen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Exagen	0 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	3.00
The Pennant Group	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60

Summary

The Pennant Group beats Exagen on 10 of the 16 factors compared between the two stocks.